| View |
|
DRP-14345-01
|
Ascorbic Acid
|
None
|
500 mg
|
Tablet
|
Vitamin
|
Huazhong Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
10 October 2023
|
23 August 2028
|
| View |
|
DRP-14345-02
|
Ascorbic Acid
|
Redvit-C
|
500 mg
|
Tablet
|
Vitamin
|
Huazhong Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
12 October 2023
|
23 August 2028
|
| View |
|
DRP-14434-01
|
Nicardipine Hydrochloride
|
Nikem
|
1 mg / mL
|
Solution for IV Infusion
|
Calcium Channel Blocker
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
04 October 2023
|
15 February 2028
|
| View |
|
DRP-1538-08
|
Diphenhydramine Hydrochloride
|
TG-Dypenmax
|
12.5 mg/ 5 mL
|
Syrup
|
H1-Receptor Antagonist (Antihistamine)
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
12 October 2023
|
02 January 2027
|
| View |
|
DRP-1651-05
|
Folic Acid
|
Cefolic
|
5 mg
|
Tablet
|
Vitamin / Hematinic
|
LifeSquare Laboratories, Inc
|
Philippines
|
Renewal
|
29 March 2024
|
25 September 2029
|
| View |
|
DRP-1995-02
|
Multivitamins
|
Enerkids
|
|
Syrup (Oral Drops)
|
Vitamins
|
New Myrex Laboratories, Inc
|
Philippines
|
Renewal
|
20 October 2024
|
15 October 2029
|
| View |
|
DRP-221-01
|
Dydrogesterone
|
None
|
10 mg
|
Tablet
|
Progesterone (Pregnadien derivative)
|
Abbott Biologicals B.V
|
Netherlands
|
CLIDP Conversion
|
10 October 2023
|
12 July 2027
|
| View |
|
DRP-2470-14
|
CLOPIDOGREL
|
CLOTIN
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
Renewal
|
20 October 2024
|
02 February 2030
|
| View |
|
DRP-2591-07
|
Losartan Potassium
|
BPbest
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Synmedic Laboratories
|
India
|
CLIDP Conversion
|
10 October 2023
|
31 July 2028
|
| View |
|
DRP-2672-15
|
Clopidogrel (as bisulfate)
|
Neoclopid
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic (Platelet Aggregation Inhibitors)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 October 2023
|
04 January 2029
|
| View |
|
DRP-2836-10
|
Salbutamol + Guaifenesin
|
Salbucam
|
1 mg / 50 mg per 5 mL
|
Syrup
|
Selective Beta-2-Adrenoreceptor Agonist / Expectorant
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
04 October 2023
|
09 March 2026
|
| View |
|
DRP-294-13
|
Co-Amoxiclav
|
Cobiokids
|
250 mg/62.5 mg per 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor Combination)
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
14 September 2023
|
06 September 2026
|
| View |
|
DRP-3047-11
|
Omeprazole
|
Obax-20
|
20 mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
06 February 2024
|
15 June 2029
|
| View |
|
DRP-3231-16
|
Cefuroxime (as Axetil)
|
Cefuwest
|
250 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Cephalosporin)
|
LifeSquare Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 September 2023
|
07 September 2028
|
| View |
|
DRP-4413-03
|
Hydrocortisone (as sodium succinate)
|
Corticare 250
|
250 mg
|
Powder for Injection (IM/IV)
|
Corticosteroid
|
Amson Vaccines & Pharma (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
11 September 2023
|
10 June 2025
|
| View |
|
DRP-4621-01
|
Hyoscine-N-Butylbromide
|
None
|
10 mg
|
Sugar-Coated Tablet
|
Anticholinergic/Antispasmodic
|
Bal Pharma Limited
|
India
|
CLIDP Conversion
|
04 October 2023
|
27 August 2028
|
| View |
|
DRP-4684-01
|
Hydroxyzine Hydrochloride
|
Ziltem IM
|
50 mg/mL
|
Solution for Injection (IM)
|
Antihistamine (H1-Receptor Antagonist)
|
Norris Medicines Limited
|
India
|
CLIDP Conversion
|
05 September 2023
|
06 September 2028
|
| View |
|
DRP-4762-08
|
Telmisartan
|
None
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Scott-Edil Pharmacia Limited
|
India
|
CLIDP Conversion
|
11 October 2023
|
30 September 2028
|
| View |
|
DRP-4765-08
|
Telmisartan
|
None
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Scott-Edil Pharmacia Ltd
|
India
|
Renewal
|
12 October 2023
|
30 September 2028
|
| View |
|
DRP-4774-05
|
Cefuroxime (as Sodium)
|
Axebac
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Phil Inter Pharma Co., Ltd.
|
Vietnam
|
CLIDP Conversion
|
22 September 2023
|
09 January 2028
|